FAQs on Developing EMA Policy 0070 Submissions
This blog answers audience questions posed during our RAPS webinar, How to Plan for a…
CertaraSeptember 15, 2025
What are the biggest roadblocks still standing in the way of cell and gene therapy commercialization?
Explore the top challenges in cell & gene therapy commercialization, featuring expert insights from Fran…
CertaraSeptember 12, 2025
The Top 10 Things You Need to Know About ADNCA Datasets
Learn how ADNCA datasets can modernize non-compartmental analysis: enhanced compliance, automations, and faster PK data…
CertaraSeptember 11, 2025
TrialAssure & Certara Joint Webinar: Authoring Clinical Documents with Downstream Regulatory Requirements in Mind
Watch our on-demand webinar from Certara and TrialAssure to learn how to author clinical documents…
CertaraSeptember 10, 2025
Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research
The article, "Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research," explores a…
Danielle PillsburySeptember 10, 2025
What is a Loading Dose?
Learn what a loading dose is, why it's vital for reaching therapeutic drug levels swiftly,…
CertaraSeptember 10, 2025
Dose Optimization using the Gene Therapy Virtual Twin® Platform
This blog explains how using the Gene Therapy Virtual Twin® Platform can help optimize dosing…
CertaraSeptember 9, 2025
AI-driven drug discovery picks up as FDA pushes to reduce animal testing
AI is revolutionizing drug discovery and safety testing as drug developers adopt these technologies in…
CertaraSeptember 9, 2025
Biogen Transforms Study Metadata Management with Certara’s Metadata Repository
Discover how study metadata management, paired with CDISC standards, transformed Biogen’s clinical trial processes and…
CertaraSeptember 5, 2025
